This study is for people with head and neck cancer, including oral cavity, oropharynx, and larynx cancers. It compares two approaches to help patients get timely postoperative radiation therapy (PORT), which is radiation treatment after surgery. One approach is called ENDURE, which offers patient education and support to connect you with community resources. The other approach is "treatment as usual," which is standard care. The study wants to see if ENDURE helps patients start their PORT sooner. You may be able to join if you are 18 or older and have certain types and stages of head and neck squamous cell carcinoma. The study is currently unclear on its recruitment status and plans to enroll 532 participants.

Study design

This study is a stepped-wedge cluster randomized trial, meaning groups of cancer centers will switch from standard care to the ENDURE program over time. It plans to include 532 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The main goal is measured at 3 months, looking at when timely postoperative radiation therapy (PORT) is started.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.